January 11, 2019
WELLESLEY, Mass., Jan. 11, 2019 – As the use of Raman spectroscopy has increased among multiple industries such as healthcare, semiconductors, homeland security and others, the global market for Raman spectroscopy is continuing to evolve, according to the report “Global Markets for Raman Spectroscopy.”
The global market for Raman spectroscopy was valued at $1.8 billion in 2018 and is expected to reach $2.7 billion by 2023 at a compound annual growth rate (CAGR) of 8.9% during the forecast period, according to BCC Research.
“Raman spectroscopy has been applied to the analysis of biological samples, providing detection of changes occurring at the molecular level during the pathological transformation of the tissue,” the report notes. “The use of this technology in cancer diagnosis has shown encouraging results when used in real time and when used for minimally invasive diagnosis. Confocal Raman techniques have also been successfully applied in the analysis of the skin aging process, providing new insights into this field.”
Noninvasive Glucose Measurement Marks a Prime Market Opportunity
Conventional blood sampling techniques are painful and often have other undesirable features. Noninvasive blood sampling methods have proven to be an attractive substitute for monitoring glucose and other blood analytes. While several methods are currently under development, methods employing near-infrared spectroscopy combined with multivariate regression analysis are among the most promising.
Editors/reporters requesting analyst interviews should contact Eric Surber at firstname.lastname@example.org.
Global Markets for Raman Spectroscopy( IAS110B )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email email@example.com or visit www.bccresearch.com/media to request access to our library of market research.